Article
09 Jun 2025
GLP-1 Compounded Medications Targeted By Connecticut Attorney General
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
05 Apr 2025
Texas Court Vacates FDA's Laboratory Developed Test (LDT) Final Rule
Article
19 Mar 2025
Compounded GLP-1 Drugs: Texas Judge Denies PI Motion And Request For Stay Of FDA's Declaration That Tirzepatide Shortage Is Resolved; Plaintiff OFA Appeals
Article
20 Jan 2025
AI Drug Development: FDA Releases Draft Guidance
Article
09 Jan 2025
AI-Enabled Device Software Functions: FDA's Final Guidance For Predetermined Change Control Plans
Article
02 Jan 2025
GLP-1 Drugs: FDA "Re-Confirms" Decision Removing Tirzepatide From The Drug Shortage List
Article
27 Dec 2024
FDA Targets GLP-1 Providers With Warning Letters
Article
17 Dec 2024
Antibody Drug Conjugates Keep Growing: What You Need To Know
Article
03 Dec 2024
GLP-1 Drugs: Brand Companies Push FDA To Limit Compounding
Article
25 Oct 2024
GLP-1 Drugs: FDA Sued Over Removing Tirzepatide From The Drug Shortage List
